logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Adrian M. Senderowicz

us food & drug administration (fda)

49H指数
188论文数
9.9K被引数
收录论文 29
发表时间
logo
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2020-11-01
err18
errOAAI
errPearson, Andrew D. J.; Stegmaier, Kimberly; Bourdeaut, Franck; Reaman, Gregory; Heenen, Delphine; Meyers, Michael L.; Armstrong, Scott A.; Brown, Patrick; De Carvalho, Daniel; Jabado, Nada; Marshall, Lynley; Rivera, Miguel; Smith, Malcolm; Adamson, Peter C.; Barone, Amy; Baumann, Christian; Blackman, Samuel; Buenger, Vickie; Donoghue, Martha; Duncan, Aundrietta D.; Fox, Elizabeth; Gadbaw, Brian; Hattersley, Maureen; Ho, Peter; Jacobs, Ira; Kelly, Michael J.; Kieran, Mark; Lesa, Giovanni; Ligas, Franca; Ludwinski, Donna; McDonough, Joe; Nikolova, Zariana; Norga, Koen; Senderowicz, Adrian; Taube, Tilmann; Weiner, Susan; Karres, Dominik; Vassal, Gilles
err分享
err收藏
Phase Ib results of ProSTAR: CPI-1205, EZH2 inhibitor, combined with enzalutamide (E) or abiraterone/prednisone (A/P) in patients with metastatic castration-resistant prostate cancer (mCRPC)
errCANCER RESEARCH
IF16.6
err2019-07-01
err10
PREAI
errTaplin, Mary-Ellen; Hussain, Arif; Shah, Satish; Shore, Neal D.; Edenfield, William Jeffery; Sartor, Oliver A.; Nordquist, Luke T.; Agrawal, Manish; Clark, William; Wise, David R.; Oh, William K.; Fleming, Mark T.; Butrynski, James E.; Chatta, Gurkamal S.; Bupathi, Manojkumar; Lebedinsky, Claudia; Senderowicz, Adrian; Li, Jian; Colak, Gozde; Nash, David; Trojer, Patrick; Bradley, William D.; Piel, Jessica; Antonarakis, Emmanuel S.
err分享
err收藏
A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinomaCRLX101联合贝伐单抗与标准治疗晚期肾细胞癌患者的随机II期试验
errANNALS OF ONCOLOGY
IF65.4
err2017-11-01
err60
errOAAI
errVoss, M. H.; Hussain, A.; Vogelzang, N.; Lee, J. L.; Keam, B.; Rha, S. Y.; Vaishampayan, U.; Harris, W. B.; Richey, S.; Randall, J. M.; Shaffer, D.; Cohn, A.; Crowell, T.; Li, J.; Senderowicz, A.; Stone, E.; Figlin, R.; Motzer, R. J.; Haas, N. B.; Hutson, T.
err分享
err收藏
Phase 1b/2 Study of Neoadjuvant Chemoradiation Therapy With CRLX101 and Capecitabine for Locally Advanced Rectal Cancer
errINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
err2017-10-01
err0
errOAAI
errMoon, D. H.; Mcree, A. J.; Blackstock, A. W.; O'Neil, B. H.; Moore, D. T.; Calvo, B. F.; Lee, M. S.; Murphy, C.; Caliri, K.; Tynan, M. T.; Senderowicz, A. M.; Tepper, J. E.; Sanoff, H. K.; Wang, A. Z.
err分享
err收藏
Significant improvements in therapeutic index for conjugated payloads using a nanoparticle-drug conjugate (NDC) platform to provide sustained drug release and potentially improved anticancer effects
errCANCER RESEARCH
IF16.6
err2017-01-16
err0
PREAI
errMetcalf, Chester, III; Van der Poll, Derek; Zhao, Liang; Halo, Tiffany; Lazarus, Doug; Stockmann, Adam; Peters, Christian; Brown, Donna; Case, Roy; Rohde, Ellen; Jayaraman, Lata; Wang, Hongwei; Crowell, Tiffany; Senderowicz, Adrian; Eliasof, Cott
err分享
err收藏
A phase 1b study of the nanoparticle-drug conjugate (NDC) CRLX101 in combination with weekly paclitaxel in patients (pts) with platinum-resistant ovarian cancer (OC)
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err1
errOAAI
errKrasner, C. N.; Schilder, R. J.; Brady, W. E.; Duska, L. R.; O'Malley, D.; Disilvestro, A.; Li, J.; Downing, W.; Senderowicz, A.
err分享
err收藏
A dose-escalation study of weekly intravenous CRLX301 in patients with advanced solid tumor malignancies
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err1
errOAAI
errWang, H.; Markman, B.; de Souza, P.; Dees, E. C.; Gangadhar, T. C.; Piha-Paul, S. A.; Zamboni, W. C.; Murphy, C.; Senderowicz, A.
err分享
err收藏
Evaluation of weekly dosing of CRLX101 alone and in combination with bevacizumab (bev) in patients (pts) with advanced solid tumors
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err4
errOAAI
errLakhani, N.; Piha-Paul, S. A.; Senderowicz, A.; Caliri, K.; Crowell, T.; Wang, H.; Tolcher, A.
err分享
err收藏
Pharmacokinetics (PK) of CRLX101 administered weekly in patients (pts) with advanced solid tumors
errANNALS OF ONCOLOGY
IF65.4
err2016-10-01
err0
errOAAI
errWang, H.; Zamboni, W.; Tolcher, A.; Lakhani, N.; Piha-Paul, S. A.; Caliri, K.; Crowell, T.; Senderowicz, A.
err分享
err收藏
Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial
errANNALS OF ONCOLOGY
IF65.4
err2016-08-01
err47
errOAAI
errKeefe, S. M.; Hoffman-Censits, J.; Cohen, R. B.; Mamtani, R.; Heitjan, D.; Eliasof, S.; Nixon, A.; Turnbull, B.; Garmey, E. G.; Gunnarsson, O.; Waliki, M.; Ciconte, J.; Jayaraman, L.; Senderowicz, A.; Tellez, A. B.; Hennessy, M.; Piscitelli, A.; Vaughn, D.; Smith, A.; Haas, N. B.
err分享
err收藏
Pharmacokinetics (PK) of CRLX301 a novel nanoparticle-drug conjugate (NDC) containing the payload docetaxel, in patients with refractory solid tumors
errCANCER RESEARCH
IF16.6
err2016-07-15
err4
PREAI
errZamboni, William C.; Markman, Ben; De Souza, Paul; Dees, E. Claire; Gangadhar, Tara; Eliasof, Scott; Murphy, Curran; Senderowicz, Adrian; Wang, Hongwei
err分享
err收藏
Phase II trial of the NDC CRLX101 in combination with bevacizumab in patients with platinum-resistant ovarian cancer (PROC)
errCANCER RESEARCH
IF16.6
err2016-07-15
err3
PREAI
errKrasner, Carolyn; Birrer, Michael; Peters, Christian; Jayaraman, Lata; Eliasof, Scott; Tellez, Andres; Downing, William; Senderowicz, Adrian
err分享
err收藏
Enhanced Skin Carcinogenesis and Lack of Thymus Hyperplasia in Transgenic Mice Expressing Human Cyclin D1b (CCND1b)
errMOLECULAR CARCINOGENESIS
IF3.2
err2008-10-21
err15
errOAAI
errRojas, Paola; Benavides, Fernando; Blando, Jorge; Perez, Carlos; Cardenas, Kim; Richie, Ellen; Knudsen, Erik S.; Johnson, David G.; Senderowicz, Adrian M.; Rodriguez-Puebla, Marcelo L.; Conti, Claudio J.
err分享
err收藏
S-Phase-specific activation of PKCα induces senescence in non-small cell lung cancer cells
errJOURNAL OF BIOLOGICAL CHEMISTRY
IF3.9
err2008-02-01
err55
errOAAI
errOliva, Jose L.; Caino, M. Cecilia; Senderowicz, Adrian M.; Kazanietz, Marcelo G.
err分享
err收藏
Expression of CDK4 or CDK2 in mouse oral cavity is retained in adult pituitary with distinct effects on tumorigenesis
errCANCER RESEARCH
IF16.6
err2008-01-02
err17
errOAAI
errMacias, Everardo; de Marva, Paula L. Miliani; Senderowicz, Adrian; Cullen, John; Rodriguez-Puebla, Marcelo L.
err分享
err收藏
Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1
errCANCER RESEARCH
IF16.6
err2005-04-15
err71
errOAAI
errAguero, MF; Facchinetti, MM; Sheleg, Z; Senderowicz, AM
err分享
err收藏
RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells
errCANCER RESEARCH
IF16.6
err2005-04-01
err57
errOAAI
errMukhopadhyay, UK; Senderowicz, AM; Ferbeyre, G
err分享
err收藏
Effects of α1-acid glycoprotein on the clinical pharmacokinetics of 7-hydroxystaurosporine
errCLINICAL CANCER RESEARCH
IF10.2
err2004-10-22
err24
errOAAI
errSparreboom, A; Chen, HC; Acharya, MR; Senderowicz, AM; Messmann, RA; Kuwabara, T; Venzon, DJ; Murgo, AJ; Headlee, D; Sausville, EA; Figg, WD
err分享
err收藏
UCN-01-induced cell cycle arrest requires the transcriptional induction of p21waf1/cip1 by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway
errCANCER RESEARCH
IF16.6
err2004-05-17
err56
errOAAI
errFacchinetti, MM; De Siervi, A; Toskos, D; Senderowicz, AM
err分享
err收藏
Advances in molecular carcinogenesis: Current and future use of mouse models to screen and validate molecularly targeted anticancer drugs
errMOLECULAR CARCINOGENESIS
IF3.2
err2004-03-25
err19
PREAI
errFrijhoff, AFW; Conti, CJ; Senderowicz, AM
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
E
Elaine S. Jaffe
H 指数: 167 · 论文数: 1.2K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
G
GutkindJ.Silvio (J. Silvio Gutkind)
H 指数: 140 · 论文数: 1.3K
M
Michael J. Birrer
H 指数: 126 · 论文数: 1.1K
N
Nicholas J. Vogelzang
H 指数: 115 · 论文数: 1.1K
查看更多